Shopping Cart
- Remove All
Your shopping cart is currently empty
HDAC-IN-27 is a potent and orally active inhibitor of HDAC Class I (0.43 nM - 3.01 nM for HDAC1-3). HDAC-IN-27 shows activity against anti-acute myeloid leukemia (AML).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks |
| Description | HDAC-IN-27 is a potent and orally active inhibitor of HDAC Class I (0.43 nM - 3.01 nM for HDAC1-3). HDAC-IN-27 shows activity against anti-acute myeloid leukemia (AML). |
| In vitro | In wild-type p53 MV4-11 cells, HDAC-IN-27 (11h) promotes pro-caspase-3 cleavage, triggers apparent apoptotic cell death, and increases the sub-G1 cell population. Conversely, it induces G2/M arrest in HL60 cells without showing signs of apoptosis [1]. |
| Molecular Weight | 350.41 |
| Formula | C20H22N4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.